Yi Bo, Jiang Juan, Zhu Liyong, Li Pengzhou, Im Ibrahim, Zhu Shaihong
Department of General Surgery, Third Xiangya Hospital, Central South University, People's Republic of China.
Department of Surgery, Englewood Hospital and Medical Center, New Jersey.
Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1061-8. doi: 10.1016/j.soard.2014.12.029. Epub 2015 Jan 5.
Based on distinct epidemiologic features of Chinese type 2 diabetes mellitus (T2DM) patients, who tend to have abdominal fat deposition, but with normal or mildly overweight epidemiologic features, our center initially had treated T2DM with body mass index (BMI)<35 kg/m² by performing laparoscopic Roux-en-Y gastrojejunostomy since 2008. This procedure is successful in treating abnormal glucose metabolism but not in improving abdominal visceral obesity. However, since 2011, laparoscopic Roux-Y gastric bypass (LRYGB) with a small stomach pouch has been performed at our center, with prominent resolution of abdominal visceral obesity and lower incidences of postoperative complications. The purpose of the present study was to formally compare these different procedures.
From 2011 to 2013, 60 patients who met the NIH criteria were recruited and randomly assigned to undergo either laparoscopic Roux-en-Y gastrojejunostomy (n = 30) or LRYGB with a small stomach pouch (n = 30). All of the patients were followed for 12 months, and pre- and postoperative changes in BMI, waist circumference, fasting plasma glucose (FPG), postprandial plasma glucose (PBG), glycated hemoglobin (HbA1c), homoeostatic model assessment (HOMA-IR), the body fat rate and major complications were recorded.
Both procedures were successful in reducing HbA1c, FPG, and PBG levels and HOMA-IR scores. However, LRYGB with a small stomach pouch resulted in a greater reduction in FPG, PBG, and HbA1c levels, and HOMA-IR scores compared with Roux-en-Y gastrojejunostomy. In addition, the reductions in BMI, body fat content, waist circumference, and the incidence of postoperative marginal ulcers in the small-stomach-pouch LRYGB were significant.
Both procedures are effective treatments for T2DM patients with BMI<35 kg/m². However, the advantages of resolved abnormal glucose metabolism and abdominal visceral obesity and decreased incidences of surgical complications are more obvious for LRYGB with a small gastric pouch. Potentially, LRYGB with a small gastric pouch is more suitable for Chinese diabetic patients with BMI <35 kg/m².
基于中国2型糖尿病(T2DM)患者独特的流行病学特征,即倾向于腹部脂肪堆积,但流行病学特征为正常或轻度超重,自2008年以来,我们中心最初通过实施腹腔镜Roux-en-Y胃空肠吻合术来治疗体重指数(BMI)<35kg/m²的T2DM患者。该手术在治疗糖代谢异常方面取得成功,但在改善腹部内脏肥胖方面效果不佳。然而,自2011年起,我们中心开展了小胃囊腹腔镜Roux-Y胃旁路术(LRYGB),在改善腹部内脏肥胖方面效果显著,且术后并发症发生率较低。本研究旨在对这两种不同手术进行正式比较。
2011年至2013年,招募了60例符合美国国立卫生研究院(NIH)标准的患者,并随机分为两组,分别接受腹腔镜Roux-en-Y胃空肠吻合术(n = 30)或小胃囊LRYGB(n = 30)。所有患者均随访12个月,记录术前及术后BMI、腰围、空腹血糖(FPG)、餐后血糖(PBG)、糖化血红蛋白(HbA1c)、稳态模型评估(HOMA-IR)、体脂率及主要并发症的变化情况。
两种手术均成功降低了HbA1c、FPG、PBG水平及HOMA-IR评分。然而,与Roux-en-Y胃空肠吻合术相比,小胃囊LRYGB在降低FPG、PBG及HbA1c水平和HOMA-IR评分方面效果更显著。此外,小胃囊LRYGB在降低BMI、体脂含量、腰围及术后边缘溃疡发生率方面效果显著。
两种手术对BMI<35kg/m²的T2DM患者均有效。然而,小胃囊LRYGB在解决糖代谢异常和腹部内脏肥胖以及降低手术并发症发生率方面优势更明显。小胃囊LRYGB可能更适合BMI<35kg/m²的中国糖尿病患者。